论文信息 - Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy - 字舞流文

Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

E. Laurenti | John Frederick Rudge | G. Follows | K. Ardeshna | D. O'mahony | P. McKay | S. Booth | P. Brice | T. Menne | E. Gallop‐Evans | A. Mathur | S. Iyengar | D. Culligan | N. Martínez-Calle | E. Phillips | K. Linton | G. Collins | A. McMillan | K. Cwynarski | M. Furtado | N. Shah | N. Phillips | G. Stafford | W. Osborne | B. Uttenthal | A. Hodson | K. Bhuller | N. Chavda | O. Lomas | A. Davies | A. Santarsieri | T. Creasey | D. Dutton | N. Wetherall | K. Sturgess | P. J. Campbell | S. Behan | S. Nagumantry | R. Trickey | E. Mitchell | S. Jones | D. Hopkins | H. Hsu | A. Sternberg | A. Downing | M. Stratton